drugset / Trial / NCT04457856
A Study of TJ003234 in Rheumatoid Arthritis Patients
RandomizedParallel-groupSingle-blindTreatment
Summary
Study Purpose and Design: A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose and Multiple Ascending Doses of TJ003234 in Rheumatoid Arthritis Patients.
Timeline
- Start
- 2020-08-06
- Primary completion
- 2023-03
- Completion
- 2023-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Plonmarlimab | Monoclonal antibody | 0.3 mg/kg | Intravenous |
| Subject | Plonmarlimab | Monoclonal antibody | 1 mg/kg | Intravenous |
| Subject | Plonmarlimab | Monoclonal antibody | 3 mg/kg | Intravenous |
| Subject | Plonmarlimab | Monoclonal antibody | 6 mg/kg | Intravenous |
| Subject | Plonmarlimab | Monoclonal antibody | 10 mg/kg | Intravenous |